FILED AND SPONSOR-REPORTED ETF HOLDINGS
CDNA Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding CDNA
8 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 3.384091% | 2026-01-30 (baseline) | 2026-04-30 |
| HELX | Franklin Genomic Advancements ETF | 0.601329% | 2025-12-31 (baseline) | 2026-03-31 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.339857% | 2026-04-30 (baseline) | 2026-04-30 |
| GSSC | Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 0.153812% | 2025-11-30 (baseline) | 2026-02-28 |
| EES | WisdomTree U.S. SmallCap Fund | 0.085303% | 2025-12-31 (baseline) | 2026-03-31 |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.084891% | 2026-01-31 (baseline) | 2026-04-30 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.018536% | 2026-01-31 (baseline) | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.001326% | 2025-12-31 (baseline) | 2026-03-31 |